Scrip Awards 2018
The 14th Annual Scrip Awards
28 November 2018
Entries are now open for the 14th Annual Scrip Awards. Since they began, the Scrip Awards has sought to applaud the essential role that the pharmaceutical, biotech and other allied industries play in improving healthcare. Its trophies span the entire range of industry activities, from new drug launches and clinical trials, to innovative deals, outsourcing and fundraising.
This year, we have introduced a new category – Best Use of Real-World Evidence – to reflect the growing importance of real-world evidence to the sector in understanding the value of drugs in the market and not just the highly controlled environment of the clinical trial.
Over the past 13 years, The Scrip Awards has carved out a unique place in the industry calendar, with around 500 attendees coming from around the world to the prestigious ceremony, which this year will take place in the London Hilton on Park Lane in Mayfair on 28 November.
Our panel of 17 highly respected and independent experts from across the sector is waiting to judge the entries from the 16 categories in contention this year. You will find further details about our panel and how the judging process works on the Judges page.
Now is the time to prepare your entry and make sure you take your place among the best.
IQVIA™ is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward.
IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of Human Data Science a reality. IQVIA’s approach to Human Data Science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, advanced technology and analytics with extensive industry knowledge. To learn more, visit www.iqvia.com.
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Skipta is the leading social network of specialized online medical communities for verified healthcare professionals (HCPs). Skipta’s growing network of more than 30 specialty communities allow verified HCPs to communicate and collaborate with peers in a focused, secure environment. The company enables pharmaceutical and biotech brands to drive awareness and behavior change by bringing to them multi-channel access to 800,000+ verified HCPs through integrated engagement programs.
One of the world’s leading, full-service contract research organizations (CROs), Worldwide Clinical Trials employs more than 1,400 professionals around the world. Grounded in medicine and science, we strive to help patients live longer, better lives by partnering with pharmaceutical and biotechnology companies to bring new drug and device discoveries to market. Our employees are among the best in their fields – medical, scientific, and research professionals – who are committed to the well-being of all our clinical trial participants.
WuXi AppTec is a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China, U.S., and Iceland. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Our services are designed to help our global partners in shortening the cycle and lowering the cost of drug and medical device R&D through cost-effective and efficient solutions.
WuXi started with four founders and a single laboratory in December 2000. Today, we have over 10,000 employees globally and about 5 million square feet of laboratory and manufacturing space, enabling over 2,000 innovative collaborators worldwide through our end-to-end capability and technology platform. Together with our partners, we are advancing breakthroughs in science, medicine, and health that aim to help people around the world to lead happier and healthier lives.
Medidata is reinventing global drug development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including nearly 850 global pharmaceutical companies, biotech, diagnostic and device firms, academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® is the primary technology platform powering clinical trials for 17 of the world's top 25 pharmaceutical companies, and is used by 16 of the top 20 medical device developers—from study design and planning through execution, management and reporting.
Founded in 1978, Lachman Consultants provides expert compliance, regulatory affairs, and technical services to clients around the world. Lachman helps organizations to prevent and resolve compliance problems and to develop efficient and effective strategies for the submission and approval of drugs and devices. The company deploys only highly experienced consultants who consistently deliver top quality results for a diverse base of global clients—including pharmaceutical, biotechnology, medical device, and dietary supplement companies and the law firms that serve them.